China to track poorly stored vaccines sold illegally

March 22, 2016

China's Food and Drug Administration has ordered local governments to track the whereabouts of poorly refrigerated and probably ineffective vaccines after police detained a woman thought to have sold nearly $100 million worth of the suspect products nationwide.

The scandal has reawakened longstanding concerns among the public over the safety of food and medicine. Nine pharmaceutical wholesalers believed to have sold the vaccines are being investigated.

The administration on Monday ordered a thorough check on where the vaccines were distributed and how they may have been used. The central government administration demanded local authorities investigate the nine wholesalers believed to have sold the vaccines.

The vaccines included those for hepatitis B, rabies, mumps and Japanese encephalitis. Poorly stored vaccines may lose their potency and cause side effects.

A 47-year-old former doctor has been detained in the eastern province of Shandong for allegedly selling the vaccines to nationwide distributors. Police told state media that the suspect, identified by her last name Pang, had earlier been convicted of illegally selling vaccines in 2009 and sentenced to three years in prison. She was released after the sentence was suspended for five years.

State media reports say Pang sold about 2 million doses of suspect vaccines. Shandong's provincial food and drug safety administration has publicized a list of buyers and sellers.

Amid widespread counterfeiting and lax enforcement, China has struggled to ensure food and drug safety. Past scandals have involved phony infant formula discovered to be nothing but starch and bogus vaccines containing only saline solution.

Explore further: Beneficial co-contribution of rotavirus vaccines and pneumococcal conjugate vaccines

Related Stories

Italy lifts ban on Novartis flu vaccines

November 9, 2012

Italian health authorities on Friday lifted a ban on the sale of flu vaccines made by Swiss pharmaceutical giant Novartis, saying that tests had shown they were not a health risk.

EU drug regulator starts safety review of HPV vaccines

July 13, 2015

The European Medicines Agency says it has started a review of cervical cancer vaccines to see if they are linked to two rare conditions, but emphasized it hasn't changed its recommendations for how the shots should be used.

Recommended for you

Experts question push for 'abuse-deterrent' Rx opioids

June 1, 2017

In response to the rise in opioid overdose deaths nationwide, pharmaceutical companies have developed formulations of prescription opioids designed to prevent tampering or abuse. These "abuse-deterrent" forms, however, are ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.